top of page
Reducing maternal and children mortality through the development of safe, effective and affordable vaccines against placental malaria
NEWS
Understanding communities to improve vaccine uptake: new EVI-led study sheds light onto malaria-in-pregnancy vaccine acceptance in Malawi
A new publication in Vaccines reflects this commitment. Led by EVI in collaboration with the Malawi University of Science and Technology (MUST), a community-based cross-sectional survey was conducted among women of reproductive age in southern Malawi.
Apr 24
A roadmap for Malaria-in-pregnancy vaccines: ADVANCE-VAC4PM Workshop findings now published
The workshop integrated scientific, regulatory, cost-effectiveness, and socio-behavioural perspectives, providing a platform for coordinated dialogue among global stakeholders on development, evaluation, and implementation strategies.
Mar 30
ADVANCE-VAC4PM at ASTMH 2025: Driving maternal health innovation
The ADVANCE-VAC4PM project was represented at the ASTMH 2025 Annual Meeting, highlighting ongoing efforts to improve maternal and neonatal health through the development of a placental malaria vaccine, a critical tool for protecting mothers and babies in malaria-endemic regions.
Nov 17, 2025
bottom of page